HEADER VIRAL PROTEIN, HYDROLASE/INHIBITOR 16-JUN-22 8DCH TITLE CRYSTAL STRUCTURE OF A HIGHLY RESISTANT HIV-1 PROTEASE CLINICAL TITLE 2 ISOLATE PR10X WITH GRL-0519 (TRIS-TETRAHYDROFURAN AS P2 LIGAND) COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PR,RETROPEPSIN; COMPND 5 EC: 3.4.23.16; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 STRAIN: CLINICAL ISOLATE PR76VMX; SOURCE 5 GENE: GAG-POL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS HIV/AIDS, HIV PROTEASE, DRUG RESISTANT CLINICAL MUTANT, EVOLUTION OF KEYWDS 2 DRUG RESISTANCE, DISTAL MUTATIONS, VIRAL PROTEIN, HYDROLASE- KEYWDS 3 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.E.WONG-SAM,Y.-F.WANG,I.T.WEBER REVDAT 2 18-OCT-23 8DCH 1 REMARK REVDAT 1 05-OCT-22 8DCH 0 JRNL AUTH A.WONG-SAM,Y.F.WANG,D.W.KNELLER,A.Y.KOVALEVSKY,A.K.GHOSH, JRNL AUTH 2 R.W.HARRISON,I.T.WEBER JRNL TITL HIV-1 PROTEASE WITH 10 LOPINAVIR AND DARUNAVIR RESISTANCE JRNL TITL 2 MUTATIONS EXHIBITS ALTERED INHIBITION, STRUCTURAL JRNL TITL 3 REARRANGEMENTS AND EXTREME DYNAMICS. JRNL REF J.MOL.GRAPH.MODEL. V. 117 08315 2022 JRNL REFN ISSN 1093-3263 JRNL PMID 36108568 JRNL DOI 10.1016/J.JMGM.2022.108315 REMARK 2 REMARK 2 RESOLUTION. 1.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELX 1997 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 67583 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : NULL REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE (F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1522 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 50 REMARK 3 SOLVENT ATOMS : 213 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : NULL REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : NULL REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : NULL REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : NULL REMARK 3 NUMBER OF RESTRAINTS : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.013 REMARK 3 ANGLE DISTANCES (A) : 0.035 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.034 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.080 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.086 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.020 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.005 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.052 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.092 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: MOEWS & KRETSINGER, J.MOL.BIOL.91(1973)201-228 REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: ANISOTROPIC REFINEMENT REDUCED FREE R REMARK 3 (NO CUTOFF) BY ? REMARK 4 REMARK 4 8DCH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-JUN-22. REMARK 100 THE DEPOSITION ID IS D_1000266419. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-OCT-17 REMARK 200 TEMPERATURE (KELVIN) : 100.000 REMARK 200 PH : 5.20 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX300HE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 67583 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.250 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 6.800 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.29 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.38900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 3NU3 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: HANGING-DROP VAPOR DIFFUSION USING REMARK 280 EQUAL VOLUMES OF PROTEIN STOCK (3.9 MG/ML) AND WELL RESERVOIR REMARK 280 SOLUTION. CRYOPROTECTED IN 30% GLYCEROL. COMPLEX ON ICE AT 1:8 REMARK 280 RATIO OF PR TO PI, CRYSTALLIZED IN 1 M NACL AND 0.1 M SODIUM REMARK 280 ACETATE PH 5.2, PH 5.20, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 39.07750 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 19.53875 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 58.61625 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4420 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9510 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -41.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLU A 21 CB - CG - CD ANGL. DEV. = 19.5 DEGREES REMARK 500 GLU A 21 OE1 - CD - OE2 ANGL. DEV. = -11.2 DEGREES REMARK 500 GLU A 21 CG - CD - OE2 ANGL. DEV. = 13.2 DEGREES REMARK 500 ARG A 41 CD - NE - CZ ANGL. DEV. = 13.3 DEGREES REMARK 500 ARG A 41 NE - CZ - NH1 ANGL. DEV. = 4.2 DEGREES REMARK 500 LYS A 45 CA - C - O ANGL. DEV. = 13.2 DEGREES REMARK 500 ILE A 46 C - N - CA ANGL. DEV. = -17.8 DEGREES REMARK 500 ILE A 47 C - N - CA ANGL. DEV. = 15.7 DEGREES REMARK 500 PHE B 53 CB - CG - CD1 ANGL. DEV. = 4.6 DEGREES REMARK 500 ARG B 87 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 ARG B 87 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 35 53.62 -93.43 REMARK 500 ASN B 35 53.02 -95.42 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue G52 A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL B 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 102 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6DJ5 RELATED DB: PDB REMARK 900 MUTATION L76V HIV-1 PROTEASE WITH GRL-0519 REMARK 900 RELATED ID: 3PWM RELATED DB: PDB REMARK 900 MUTATION L76V HIV-1 PROTEASE WITH DARUNAVIR REMARK 900 RELATED ID: 3PWR RELATED DB: PDB REMARK 900 MUTATION L76V HIV-1 PROTEASE WITH SAQUINAVIR REMARK 900 RELATED ID: 6DJ2 RELATED DB: PDB REMARK 900 MUTATION L76V HIV-1 PROTEASE WITH LOPINAVIR REMARK 900 RELATED ID: 6DIL RELATED DB: PDB REMARK 900 MUTATION L76V HIV-1 PROTEASE WITH TIPRANAVIR REMARK 900 RELATED ID: 8DCI RELATED DB: PDB REMARK 900 HIV-1 PROTEASE CLINICAL ISOLATE PR10X IN THE LIGAND-FREE STRUCTURE DBREF 8DCH A 1 99 UNP P03367 POL_HV1BR 501 599 DBREF 8DCH B 1 99 UNP P03367 POL_HV1BR 501 599 SEQADV 8DCH LYS A 7 UNP P03367 GLN 507 ENGINEERED MUTATION SEQADV 8DCH PHE A 10 UNP P03367 LEU 510 ENGINEERED MUTATION SEQADV 8DCH VAL A 13 UNP P03367 ILE 513 ENGINEERED MUTATION SEQADV 8DCH ILE A 19 UNP P03367 LEU 519 ENGINEERED MUTATION SEQADV 8DCH THR A 20 UNP P03367 LYS 520 ENGINEERED MUTATION SEQADV 8DCH ILE A 32 UNP P03367 VAL 532 ENGINEERED MUTATION SEQADV 8DCH ILE A 33 UNP P03367 LEU 533 ENGINEERED MUTATION SEQADV 8DCH ASN A 35 UNP P03367 GLU 535 ENGINEERED MUTATION SEQADV 8DCH ILE A 36 UNP P03367 MET 536 ENGINEERED MUTATION SEQADV 8DCH ILE A 46 UNP P03367 MET 546 ENGINEERED MUTATION SEQADV 8DCH GLN A 48 UNP P03367 GLY 548 ENGINEERED MUTATION SEQADV 8DCH LEU A 54 UNP P03367 ILE 554 ENGINEERED MUTATION SEQADV 8DCH PRO A 63 UNP P03367 LEU 563 ENGINEERED MUTATION SEQADV 8DCH GLU A 67 UNP P03367 CYS 567 ENGINEERED MUTATION SEQADV 8DCH VAL A 71 UNP P03367 ALA 571 ENGINEERED MUTATION SEQADV 8DCH SER A 74 UNP P03367 THR 574 ENGINEERED MUTATION SEQADV 8DCH VAL A 76 UNP P03367 LEU 576 ENGINEERED MUTATION SEQADV 8DCH VAL A 84 UNP P03367 ILE 584 ENGINEERED MUTATION SEQADV 8DCH VAL A 89 UNP P03367 LEU 589 ENGINEERED MUTATION SEQADV 8DCH MET A 90 UNP P03367 LEU 590 ENGINEERED MUTATION SEQADV 8DCH SER A 91 UNP P03367 THR 591 ENGINEERED MUTATION SEQADV 8DCH LEU A 93 UNP P03367 ILE 593 ENGINEERED MUTATION SEQADV 8DCH ALA A 95 UNP P03367 CYS 595 ENGINEERED MUTATION SEQADV 8DCH LYS B 7 UNP P03367 GLN 507 ENGINEERED MUTATION SEQADV 8DCH PHE B 10 UNP P03367 LEU 510 ENGINEERED MUTATION SEQADV 8DCH VAL B 13 UNP P03367 ILE 513 ENGINEERED MUTATION SEQADV 8DCH ILE B 19 UNP P03367 LEU 519 ENGINEERED MUTATION SEQADV 8DCH THR B 20 UNP P03367 LYS 520 ENGINEERED MUTATION SEQADV 8DCH ILE B 32 UNP P03367 VAL 532 ENGINEERED MUTATION SEQADV 8DCH ILE B 33 UNP P03367 LEU 533 ENGINEERED MUTATION SEQADV 8DCH ASN B 35 UNP P03367 GLU 535 ENGINEERED MUTATION SEQADV 8DCH ILE B 36 UNP P03367 MET 536 ENGINEERED MUTATION SEQADV 8DCH ILE B 46 UNP P03367 MET 546 ENGINEERED MUTATION SEQADV 8DCH GLN B 48 UNP P03367 GLY 548 ENGINEERED MUTATION SEQADV 8DCH LEU B 54 UNP P03367 ILE 554 ENGINEERED MUTATION SEQADV 8DCH PRO B 63 UNP P03367 LEU 563 ENGINEERED MUTATION SEQADV 8DCH GLU B 67 UNP P03367 CYS 567 ENGINEERED MUTATION SEQADV 8DCH VAL B 71 UNP P03367 ALA 571 ENGINEERED MUTATION SEQADV 8DCH SER B 74 UNP P03367 THR 574 ENGINEERED MUTATION SEQADV 8DCH VAL B 76 UNP P03367 LEU 576 ENGINEERED MUTATION SEQADV 8DCH VAL B 84 UNP P03367 ILE 584 ENGINEERED MUTATION SEQADV 8DCH VAL B 89 UNP P03367 LEU 589 ENGINEERED MUTATION SEQADV 8DCH MET B 90 UNP P03367 LEU 590 ENGINEERED MUTATION SEQADV 8DCH SER B 91 UNP P03367 THR 591 ENGINEERED MUTATION SEQADV 8DCH LEU B 93 UNP P03367 ILE 593 ENGINEERED MUTATION SEQADV 8DCH ALA B 95 UNP P03367 CYS 595 ENGINEERED MUTATION SEQRES 1 A 99 PRO GLN ILE THR LEU TRP LYS ARG PRO PHE VAL THR VAL SEQRES 2 A 99 LYS ILE GLY GLY GLN ILE THR GLU ALA LEU LEU ASP THR SEQRES 3 A 99 GLY ALA ASP ASP THR ILE ILE GLU ASN ILE SER LEU PRO SEQRES 4 A 99 GLY ARG TRP LYS PRO LYS ILE ILE GLN GLY ILE GLY GLY SEQRES 5 A 99 PHE LEU LYS VAL ARG GLN TYR ASP GLN ILE PRO ILE GLU SEQRES 6 A 99 ILE GLU GLY HIS LYS VAL ILE GLY SER VAL VAL VAL GLY SEQRES 7 A 99 PRO THR PRO VAL ASN VAL ILE GLY ARG ASN VAL MET SER SEQRES 8 A 99 GLN LEU GLY ALA THR LEU ASN PHE SEQRES 1 B 99 PRO GLN ILE THR LEU TRP LYS ARG PRO PHE VAL THR VAL SEQRES 2 B 99 LYS ILE GLY GLY GLN ILE THR GLU ALA LEU LEU ASP THR SEQRES 3 B 99 GLY ALA ASP ASP THR ILE ILE GLU ASN ILE SER LEU PRO SEQRES 4 B 99 GLY ARG TRP LYS PRO LYS ILE ILE GLN GLY ILE GLY GLY SEQRES 5 B 99 PHE LEU LYS VAL ARG GLN TYR ASP GLN ILE PRO ILE GLU SEQRES 6 B 99 ILE GLU GLY HIS LYS VAL ILE GLY SER VAL VAL VAL GLY SEQRES 7 B 99 PRO THR PRO VAL ASN VAL ILE GLY ARG ASN VAL MET SER SEQRES 8 B 99 GLN LEU GLY ALA THR LEU ASN PHE HET G52 A 201 84 HET CL A 202 1 HET CL B 101 1 HET GOL B 102 6 HETNAM G52 (3R,3AS,3BR,6AS,7AS)-OCTAHYDRODIFURO[2,3-B:3',2'- HETNAM 2 G52 D]FURAN-3-YL [(1S,2R)-1-BENZYL-2-HYDROXY-3-{[(4- HETNAM 3 G52 METHOXYPHENYL)SULFONYL](2-METHYLPROPYL) HETNAM 4 G52 AMINO}PROPYL]CARBAMATE HETNAM CL CHLORIDE ION HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 G52 C30 H40 N2 O9 S FORMUL 4 CL 2(CL 1-) FORMUL 6 GOL C3 H8 O3 FORMUL 7 HOH *213(H2 O) HELIX 1 AA1 GLY A 86 SER A 91 1 6 HELIX 2 AA2 GLN A 92 GLY A 94 5 3 HELIX 3 AA3 GLY B 86 SER B 91 1 6 HELIX 4 AA4 GLN B 92 GLY B 94 5 3 SHEET 1 AA1 4 GLN A 2 THR A 4 0 SHEET 2 AA1 4 THR B 96 ASN B 98 -1 O LEU B 97 N ILE A 3 SHEET 3 AA1 4 THR A 96 ASN A 98 -1 N THR A 96 O ASN B 98 SHEET 4 AA1 4 GLN B 2 THR B 4 -1 O ILE B 3 N LEU A 97 SHEET 1 AA2 8 LYS A 43 GLY A 49 0 SHEET 2 AA2 8 GLY A 52 ILE A 66 -1 O GLY A 52 N GLY A 49 SHEET 3 AA2 8 HIS A 69 VAL A 77 -1 O VAL A 71 N ILE A 64 SHEET 4 AA2 8 ILE A 32 ILE A 33 1 N ILE A 33 O VAL A 76 SHEET 5 AA2 8 VAL A 84 ILE A 85 -1 O VAL A 84 N ILE A 32 SHEET 6 AA2 8 GLN A 18 LEU A 24 1 N LEU A 23 O ILE A 85 SHEET 7 AA2 8 PHE A 10 ILE A 15 -1 N VAL A 13 O THR A 20 SHEET 8 AA2 8 GLY A 52 ILE A 66 -1 O GLU A 65 N LYS A 14 SHEET 1 AA3 8 LYS B 43 GLY B 49 0 SHEET 2 AA3 8 GLY B 52 ILE B 66 -1 O VAL B 56 N LYS B 45 SHEET 3 AA3 8 HIS B 69 VAL B 77 -1 O VAL B 71 N ILE B 64 SHEET 4 AA3 8 ILE B 32 ILE B 33 1 N ILE B 33 O VAL B 76 SHEET 5 AA3 8 VAL B 84 ILE B 85 -1 O VAL B 84 N ILE B 32 SHEET 6 AA3 8 GLN B 18 LEU B 24 1 N LEU B 23 O ILE B 85 SHEET 7 AA3 8 PHE B 10 ILE B 15 -1 N VAL B 13 O THR B 20 SHEET 8 AA3 8 GLY B 52 ILE B 66 -1 O GLU B 65 N LYS B 14 SITE 1 AC1 33 ASP A 25 GLY A 27 ALA A 28 ASP A 29 SITE 2 AC1 33 ASP A 30 ILE A 32 GLN A 48 GLY A 49 SITE 3 AC1 33 ILE A 50 PRO A 81 VAL A 82 HOH A 330 SITE 4 AC1 33 HOH A 337 HOH A 339 HOH A 344 HOH A 354 SITE 5 AC1 33 HOH A 391 ARG B 8 ASP B 25 GLY B 27 SITE 6 AC1 33 ALA B 28 ASP B 29 ASP B 30 ILE B 32 SITE 7 AC1 33 GLN B 48 GLY B 49 ILE B 50 PRO B 81 SITE 8 AC1 33 VAL B 82 HOH B 218 HOH B 245 HOH B 260 SITE 9 AC1 33 HOH B 282 SITE 1 AC2 3 GLY A 73 SER A 74 ASN A 88 SITE 1 AC3 3 GLY B 73 SER B 74 ASN B 88 SITE 1 AC4 5 GLY B 16 ILE B 46 PRO B 63 HOH B 223 SITE 2 AC4 5 HOH B 304 CRYST1 56.659 56.659 78.155 90.00 90.00 90.00 P 41 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017649 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017649 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012795 0.00000